Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Is a |
Product containing magnesium hydroxide and omeprazole and sodium bicarbonate (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sodium bicarbonate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium hydroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Omeprazole (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium-based antacid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Laxative |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trace element supplementation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent employé en néphrologie |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Is a |
Product containing sodium bicarbonate in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has manufactured dose form |
Conventional release chewable tablet (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Is a |
Product containing omeprazole in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Plays role |
Laxative therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Count of base of active ingredient |
trois |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has unit of presentation |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Is a |
Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has basis of strength substance (attribute) |
Sodium bicarbonate (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength numerator value |
20 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has basis of strength substance (attribute) |
Magnesium hydroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has precise active ingredient |
Magnesium hydroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength numerator value |
600 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has precise active ingredient |
Omeprazole (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has presentation strength numerator value |
700 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has basis of strength substance (attribute) |
Omeprazole (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
Has precise active ingredient |
Sodium bicarbonate (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|